AONL
Content by and about the American Organization for Nursing Leadership (AONL).
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
.jumbotron.styled .content, .styled.hero .content {background: none !important ; box-shadow: none !important ;
@media only screen and (min-height: 400px)
}
.jumbotron .h1, .jumbotron h1 .title {
color: #003087; font-weight: 100; font-size: 50px;
}
.hero, .jumbotron {
background:…
The Food and Drug Administration announced approval of Pfizer’s Abrysvo respiratory syncytial virus vaccine.
The Department of Health and Human Services awarded more than $1.4 billion this week to support the development of the next generation of tools and technologies to protect against COVID-19.
Virtual multidisciplinary rounds combined with other interventions can reduce patient length of stay and observation hours, according to a study.